hidden Generating Evidence to Support Health Promotion Policies: Added Sugar Labeling

Generating Evidence to Support Health Promotion Policies: Added Sugar Labeling

Authors: Dariush Mozaffarian, M.D., Dr.P.H., FAHA, Dean and Jean Mayer Professor, Tufts Friedman School of Nutrition Science and Policy; Professor of Medicine, Tufts Medical School; Renata Micha, R.D., Ph.D., Research Associate Professor, Tufts Friedman School of Nutrition Science and Policy

Preview: The mandatory labeling of added sugar content on packaged foods and beverages in the United States could generate substantial health gains and cost savings, based on a study that we published today in the American Heart Association’s journal Circulation.

hidden Four Principles to Help Control the High Cost of High Blood Pressure

Four Principles to Help Control the High Cost of High Blood Pressure

Author: Joey Granger, Ph.D., FAHA; Billy S. Guyton Distinguished Professor, Professor of Physiology and Medicine and Director, Cardiovascular-Renal Research Center, University of Mississippi Medical Center; Chair, American Heart Association Council on Hypertension

Preview: Four Principles to Help Control the High Cost of High Blood Pressure

hidden Where Heart Disease and Breast Cancer Intersect: Promoting Positive Outcomes For Both

Where Heart Disease and Breast Cancer Intersect: Promoting Positive Outcomes For Both

Laxmi Mehta, M.D., FACC, FAHA, Section Director of Preventative Cardiology and Women’s Cardiovascular Health, Sarah Ross Soter Endowed Chair in Women’s Cardiovascular Health and Associate Professor of Medicine, The Ohio State University; Chair, Writing Group, AHA Scientific Statement on Cardiovascular Disease and Breast Cancer: Where these Entities Intersect Breast cancer patients may benefit from a

hidden Equitable Access to Life-Saving Treatments is Threatened by the Cost of Drugs to Patients

Equitable Access to Life-Saving Treatments is Threatened by the Cost of Drugs to Patients

Elliott M. Antman, M.D., FAHA; Senior Physician, Brigham and Women’s Hospital; Associate Dean for Clinical and Translational Research, Harvard Medical School; Past President, American Heart Association As healthcare costs continue rising, escalating spending on pharmaceuticals warrants serious attention from healthcare stakeholders. In 2015, U.S. pharmaceuticals spending reached $309.5 billion, an increase of 8.5 percent from